BIAS
MRNA icon

Beacon Investment Advisory Services’s Moderna MRNA Stock Holding History

Beacon Investment Advisory Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.56K Hold
108
– – ﹤0.01% 646
2026
Q1 		$5.49K Buy
+108
New +$5.04K ﹤0.01% 692
2024
Q3 		– Sell
-3,447
Closed -$409K – 264
2024
Q2 		$409K Sell
3,447
-13
-0.4% -$1.65K 0.02% 184
2024
Q1 		$369K Sell
3,460
-45
-1% -$4.54K 0.02% 206
2023
Q4 		$349K Sell
3,505
-1,484
-30% -$125K 0.02% 212
2023
Q3 		$515K Sell
4,989
-83
-2% -$9.26K 0.03% 190
2023
Q2 		$616K Sell
5,072
-461
-8% -$61.5K 0.03% 180
2023
Q1 		$850K Sell
5,533
-94
-2% -$15.5K 0.04% 156
2022
Q4 		$1.01M Sell
5,627
-1
-0% -$164 0.05% 150
2022
Q3 		$666K Sell
5,628
-115
-2% -$17.4K 0.04% 171
2022
Q2 		$820K Sell
5,743
-128
-2% -$18.3K 0.04% 163
2022
Q1 		$1.01M Buy
5,871
+316
+6% +$53.2K 0.04% 163
2021
Q4 		$1.41M Buy
5,555
+630
+13% +$184K 0.05% 147
2021
Q3 		$1.9M Buy
4,925
+518
+12% +$191K 0.08% 138
2021
Q2 		$1.04M Buy
4,407
+243
+6% +$43.4K 0.04% 166
2021
Q1 		$545K Buy
+4,164
New +$603K 0.02% 195

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Beacon Investment Advisory Services's MRNA Position: Q2 2026 in Review

Beacon Investment Advisory Services held its Moderna (MRNA) position steady in Q2 2026 at 108 shares worth $7.56K. The position accounts for ﹤0.01% of the portfolio, ranked #646.

Beacon Investment Advisory Services first reported a position in MRNA in Q1 2021 and has held it in 16 quarters since. The position peaked at $1.9M in Q3 2021. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Beacon Investment Advisory Services held 108 shares of Moderna worth $7.56K as of Q2 2026.
  • Beacon Investment Advisory Services left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Beacon Investment Advisory Services's portfolio in Q2 2026, its #646 holding.
  • Beacon Investment Advisory Services first reported a position in Moderna in Q1 2021 and has held it in 16 quarters since.
  • Beacon Investment Advisory Services's Moderna position peaked at $1.9M in Q3 2021.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.